These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11574577)

  • 1. Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides.
    Werner G; Cuny C; Schmitz FJ; Witte W
    J Clin Microbiol; 2001 Oct; 39(10):3586-90. PubMed ID: 11574577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of quinupristin/dalfopristin resistance among livestock-associated Staphylococcus aureus ST9 clinical isolates.
    Yu F; Lu C; Liu Y; Sun H; Shang Y; Ding Y; Li D; Qin Z; Parsons C; Huang X; Li Y; Hu L; Wang L
    Int J Antimicrob Agents; 2014 Nov; 44(5):416-9. PubMed ID: 25218154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
    Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
    J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].
    Aydeniz Ozansoy F; Cevahir N; Kaleli İ
    Mikrobiyol Bul; 2015 Jan; 49(1):1-14. PubMed ID: 25706726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal diversity among streptogramin A-resistant Staphylococcus aureus isolates collected in French hospitals.
    Haroche J; Morvan A; Davi M; Allignet J; Bimet F; El Solh N
    J Clin Microbiol; 2003 Feb; 41(2):586-91. PubMed ID: 12574251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B; Merckoll P; Melby KK
    Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group.
    Schmitz FJ; Verhoef J; Fluit AC
    J Antimicrob Chemother; 1999 Jun; 43(6):783-92. PubMed ID: 10404317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea.
    Kim HB; Lee B; Jang HC; Kim SH; Kang CI; Choi YJ; Park SW; Kim BS; Kim EC; Oh MD; Choe KW
    Microb Drug Resist; 2004; 10(3):248-54. PubMed ID: 15383170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
    Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MIC and MBC of quinupristin/dalfopristin of erythromycin-resistant MRSA strains isolated from clinical specimens].
    Młynarczyk G; Młynarczyk A; Szymanek K; Bilewska A; Pupek J; Luczak M
    Med Dosw Mikrobiol; 2006; 58(3):199-205. PubMed ID: 17340994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the translational attenuator of 20 methicillin-resistant, quinupristin/dalfopristin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides.
    Schmitz FJ; Witte W; Werner G; Petridou J; Fluit AC; Schwarz S
    J Antimicrob Chemother; 2001 Dec; 48(6):939-41. PubMed ID: 11733488
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC
    Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
    Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.
    Pavie J; Lefort A; Zarrouk V; Chau F; Garry L; Leclercq R; Fantin B
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3061-4. PubMed ID: 12183272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals.
    Vandendriessche S; Kadlec K; Schwarz S; Denis O
    J Antimicrob Chemother; 2011 Nov; 66(11):2455-9. PubMed ID: 21868413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.
    Auckenthaler R; Courvalin P; Féger C; Roche G;
    Clin Microbiol Infect; 2000 Nov; 6(11):608-12. PubMed ID: 11168064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.